FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:729-732 August 21, 2003 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Vasseur, C. Related Article by Smits, G. PubMed Citation

The ovarian hyperstimulation syndrome is an iatrogenic complication of ovulation-induction therapy. In its most severe form, this syndrome involves massive ovarian enlargement and the formation of multiple ovarian cysts, fluid shifts resulting in extravascular fluid accumulation and intravascular volume depletion, renal failure, hypovolemic shock, and in some cases, death. The severe form is rare, with a reported incidence of 0.5 to 5 percent among patients undergoing ovulation-induction therapy.

Ovulation-induction therapy is generally initiated with gonadotropins to stimulate follicle development and growth. The intensity of the ovarian hyperstimulation syndrome is related to the degree of ovarian follicular response. Estrogens, produced by . . . [Full Text of this Article]

Source Information

From the Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Boston.

This article has been cited by other articles:

• Alvarez, C., Marti-Bonmati, L., Novella-Maestre, E., Sanz, R., Gomez, R., Fernandez-Sanchez, M., Simon, C., Pellicer, A. (2007). Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction. J. Clin. Endocrinol. Metab. 92: 2931-2937 [Abstract] [Full Text]  
• Xu, X., Ding, J., Rao, G., Shen, J., Prinz, R. A., Rana, N., Dmowski, W.P. (2007). Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Hum Reprod 22: 927-937 [Abstract] [Full Text]  
• Gomez, R., Gonzalez-Izquierdo, M., Zimmermann, R. C., Novella-Maestre, E., Alonso-Muriel, I., Sanchez-Criado, J., Remohi, J., Simon, C., Pellicer, A. (2006). Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation Model. Endocrinology 147: 5400-5411 [Abstract] [Full Text]  
• Themmen, A. P N (2005). An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130: 263-274 [Abstract] [Full Text]  
• Papanikolaou, E. G., Tournaye, H., Verpoest, W., Camus, M., Vernaeve, V., Van Steirteghem, A., Devroey, P. (2005). Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 20: 636-641 [Abstract] [Full Text]